Press Releases Items Per Page 102550 Year None202320222021202020192018201720162015201420132012201120102007 03.31.11 Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting 03.01.11 Syndax Annouces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 02.10.11 Syndax Pharmaceuticals to Present at Bio CEO & Investor Conference 01.11.11 Syndax Announced Publication of Entinostat NSCLC Data in Cancer Research 01.04.11 Syndax Pharmaceuticals to Present at Biotech Showcase 2011 12.10.10 Syndax Pharmaceuticals' Entinostat in Combination Shows Activity in Breast Cancer 12.09.10 Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients 11.10.10 Syndax Pharmaceuticals to Present at Lazard Annual Healthcare Conference 10.15.10 Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat 09.28.10 Syndax Pharmaceuticals to Present at BIO Investor Forum 09.22.10 Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum 09.16.10 Syndax Pharmaceuticals to Present at UBS 2010 Global Life Sciences Conference Pagination First page « first Previous page ‹ previous … Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Next page next › Last page last »
03.31.11 Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting
03.01.11 Syndax Annouces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer
12.09.10 Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients
